Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vonoprazan for Preventing Post-EVBL Ulcers in Liver Cirrhosis
NCT07267260Phase 2Recruiting
- Sponsor
- King Edward Medical University
- Start
- Dec 2025
- Primary completion
- Jan 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of vonoprazan in Esophageal ulcer, sponsored by King Edward Medical University. Started Dec 2025; status: recruiting.
02
Drugs
vonoprazan
03
Conditions
Esophageal ulcer
Beyond the preview
Go deeper on NCT07267260.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07267260.